Trial intelligence / Profile preview

Calcium Supplements and Fluoride Retention for Dental Caries

NCT04620252Phase 1Completed

Sponsor
University of Michigan
Start
Feb 2021
Primary completion
Mar 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, open-label trial of calcium carbonate, calcium citrate and tricalcium phosphate in dental caries, sponsored by University of Michigan. Primary endpoint: Calcium concentration in saliva. Started Feb 2021; status: completed.

02

Drugs

calcium carbonatecalcium citratetricalcium phosphate
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT04620252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04620252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call